Christina Phassouliotis
35 Poplar Rd
Parkville, VIC 3052, Australia
Parkville, VIC 3052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Effects of 6-months of SSRI use on DNA-methylation and gene expression in blood.
Journal: Brain, behavior, and immunity
Published: April 29, 2025
White Blood Cell Proportions Are Associated With Response to Psychosocial Therapy in Young People at Ultra-High Risk for Psychosis.
Journal: Biological psychiatry global open science
Published: February 24, 2025
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations.
Journal: Schizophrenia (Heidelberg, Germany)
Published: September 16, 2024
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.
Journal: Schizophrenia bulletin
Published: March 07, 2024
Prevalence of sarcopenia as a comorbid disease: A systematic review and meta-analysis.
Journal: Experimental gerontology
Published: October 22, 2019
Stability of retrospective self-reports of childhood trauma in first-episode psychosis.
Journal: Early intervention in psychiatry
Published: August 10, 2017
Risk and resilience brain networks in treatment-resistant schizophrenia.
Journal: Schizophrenia research
Published: June 01, 2017
Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis.
Journal: Psychiatry research
Published: May 24, 2017
White matter connectivity disruptions in early and chronic schizophrenia.
Journal: Psychological medicine
Published: May 23, 2017
Functional brain networks in treatment-resistant schizophrenia.
Journal: Schizophrenia research
Published: September 20, 2016
Does co-occurring borderline personality disorder influence acute phase treatment for first-episode psychosis?
Journal: Early intervention in psychiatry
Published: June 30, 2016
Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
Journal: The Journal of clinical psychiatry
Published: June 17, 2015
Last Updated: 09/26/2026